Kang Zhang (Chinese: 张康[1]) is a Chinese-American ophthalmologist specializing in ophthalmic genetics and aging processes in the eye.
[2] He was previously a Professor of Ophthalmology and the Founding Director of the Institute for Genomic Medicine at the University of California, San Diego.
In 2013, Zhang, along with Trey Ideker, identified that the molecular aging clock could be measured by blood and tissues, and made use of epigenetic markers.
[8] In 2014, Zhang, along with Yizhi Liu and Xiangdong Fu, investigated mechanisms and developed a new method of limbal stem cell repair and regeneration.
[4] Zhang has also pioneered the usage of artificial intelligence in diagnosing eye diseases.